Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,093.88
(
-0.62%
)
US TECH 100
25,986.80
(
-0.83%
)
Dow Jones
49,241.74
(
-0.50%
)
Brent Oil
100.61
(
4.02%
)
Bitcoin
77,748.00
(
-0.63%
)
News Focus
News Focus
Post# of 45313
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oxnous

Send PM Follow Ignore
Followers 0
Posts 2990
Boards Moderated 0
Alias Born 11/12/2010

oxnous

Re: Threeflight post# 36832

Friday, 12/10/2021 1:53:46 PM

Friday, December 10, 2021 1:53:46 PM

Post# of 45313
NEI is doing trials on ORAL Metformin with Stargardt's disease.

https://clinicalstudies.info.nih.gov/ProtocolDetails.aspx?id=2020-EI-0163

It would make sense if they are researching the oral, that the eye drop delivery would be studied too. And CUBT would have the inside track on that.

Has anyone called the company recently? I got the e-mail from Investor Relations yesterday, but it was after the close.


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CUBT News
More CUBT News